← Classic psychedelics

DMT

N,N-Dimethyltryptamine

An extraordinarily powerful compound capable of profoundly altering perception, consciousness and our experience of reality.

Molecular structure of N,N-dimethyltryptamine.

DMT, or N,N-dimethyltryptamine, is a naturally occurring psychedelic found in a variety of plants and detected in mammals, including humans.

It is particularly remarkable for the intensity of its effects and, when inhaled, their unusually short duration. Within moments, familiar surroundings can give way to intricate geometric patterns, extraordinary landscapes and experiences that seem to transcend ordinary perception.

DMT at a glance

Family
Tryptamines
Type
Classic psychedelic
Primary target
5-HT2A
Onset (inhaled)
Within seconds
Duration (inhaled)
5–20 minutes
Origin
Plants and mammals

What is DMT?

DMT belongs to the tryptamine family and resembles serotonin, a chemical messenger involved in mood, perception and thought. Its psychedelic effects are strongly associated with activating 5-HT2A receptors. It also acts at other receptors, and no single receptor explains the full experience.

The body breaks DMT down rapidly, mainly through an enzyme called monoamine oxidase A (MAO-A). This helps explain its short duration when inhaled. Preparations containing MAO inhibitors, such as ayahuasca, change how it is processed and can produce much longer effects.

DMT occurs in plants including Psychotria viridis and Mimosa tenuiflora, and has been detected in humans and other mammals. What it does naturally in the human body remains uncertain; its presence does not mean it normally produces psychedelic effects.

Its chemical formula is C₁₂H₁₆N₂, with a molecular mass of 188.27 g/mol.

The DMT experience

Sensory effects

Colours can become vivid and surfaces fill with shifting geometry. More immersive experiences may replace the familiar world with tunnels, chambers or elaborate landscapes. Some people describe apparently independent beings; the vividness of an encounter does not establish that it exists outside the experience.

Sound may seem altered or become part of the unfolding scene. Accounts include perceived tones or buzzing, although auditory effects are less consistently described than visual ones.

Body sensations

The onset can bring intense bodily sensations and a rapid change in awareness of the body. Familiar physical boundaries may become difficult to locate, or bodily awareness may fade altogether.

Headspace

Wonder, joy and connection can occur alongside fear, confusion or a sense of being overwhelmed. Experiences may feel deeply significant while remaining difficult to remember or interpret afterwards. Intensity alone does not make an insight true.

Self, time and space

The sense of being a separate person can diminish or disappear, often described as ego dissolution. Personal history and ordinary surroundings may become remote. Minutes can feel enormously extended, or time may seem to lose its meaning.

History and culture

Canadian chemist Richard Manske first synthesised DMT in 1931, before its psychedelic properties were understood. Brazilian researcher Oswaldo Gonçalves de Lima identified it in plant material in 1946. These scientific milestones came long after traditions involving DMT-containing plants.

In 1956, Hungarian psychiatrist and chemist Stephen Szára documented its psychedelic effects in humans. During the 1990s, Rick Strassman conducted controlled studies of its psychological and physiological effects. His later book, DMT: The Spirit Molecule, brought that work to a wider audience.

Research and uses

Researchers use DMT to study perception and consciousness, while clinical trials are exploring possible therapeutic uses. These are different kinds of research: understanding an experience does not establish a medical treatment.

Brain activity. A 2023 study combined brain imaging and electrical recordings in 20 healthy volunteers receiving intravenous DMT. Researchers observed increased communication across the brain and less separation between some networks. This helps describe what changes during the experience, but does not yet explain why particular images or sensations arise.

Entity encounters. A 2020 survey examined accounts from 2,561 people who reported encounters with apparent beings after inhaled DMT. Many described lasting personal meaning or changes in belief. Because participants were selected for having these encounters, the findings cannot tell us how common they are among all DMT users.

Depression. A small phase IIa trial published in Nature Medicine in February 2026 studied intravenous DMT with psychological support in 34 adults with moderate-to-severe depression. Symptoms improved more with DMT than placebo at two weeks. The result is promising, but larger studies are needed to establish effectiveness, longer-term outcomes and safety. DMT is not an established treatment for depression.

Risks and considerations

A short experience can still be overwhelming. DMT's rapid onset can bring intense anxiety, panic, confusion or distress. Losing awareness of ordinary surroundings also creates a risk of accidental injury.

DMT can temporarily raise heart rate and blood pressure. Interactions with medications and other compounds can add risks, and people vulnerable to psychosis may face particular concerns. Research on longer-term outcomes remains limited.

Clinical studies use screening, controlled environments and medical supervision. Their findings should not be taken as evidence that unsupervised use carries the same risks. DMT is also controlled in many countries, with legal status varying by jurisdiction.

FAQ

Is DMT the same as 5-MeO-DMT?

No. They are related but distinct compounds, with different effects and pharmacology. Their names should not be treated as interchangeable.

Does the body release DMT during dreams or at death?

This is a popular theory, but it has not been demonstrated in humans. There is no convincing evidence that the human brain releases psychedelic quantities of DMT during these events.

Is DMT addictive?

DMT is not generally associated with physical dependence or the compulsive patterns seen with many addictive drugs. That does not rule out problematic use, and research on long-term use remains limited.

Sources
  1. Barker (2018). N,N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function.
  2. Timmermann et al. (2023). Human Brain Effects of DMT Assessed via EEG-fMRI.
  3. Davis et al. (2020). Survey of Entity Encounter Experiences Occasioned by Inhaled N,N-Dimethyltryptamine.
  4. Nichols (2018). N,N-Dimethyltryptamine and the Pineal Gland: Separating Fact from Myth.
  5. A Short-Acting Psychedelic Intervention for Major Depressive Disorder (2026). Nature Medicine.